Net Loss Per Common Share - Narrative (Details) - $ / shares |
1 Months Ended | |
|---|---|---|
Aug. 31, 2026 |
May 31, 2026 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Stock issued for conversion (in shares) | 300,000 | |
| Private Placement | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Common stock issuable for warrants (in shares) | 300,000 | |
| Prefunded Warrant | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Warrants, exercise price (in usd per share) | $ 0.00001 | $ 0.00001 |
| Prefunded Warrant | Private Placement | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Common stock issuable for warrants (in shares) | 300,000 | |
| Warrants, exercise price (in usd per share) | $ 0.00001 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|